DrugPatentWatch Database Preview
Global Blood Theraps Company Profile
Email this page to a colleague
» See Plans and PricingWhat is the competitive landscape for GLOBAL BLOOD THERAPS, and what generic alternatives to GLOBAL BLOOD THERAPS drugs are available?
GLOBAL BLOOD THERAPS has one approved drug.
There are six US patents protecting GLOBAL BLOOD THERAPS drugs.
There are one hundred and fifty-three patent family members on GLOBAL BLOOD THERAPS drugs in thirty-one countries.
Summary for Global Blood Theraps
| International Patents: | 153 |
| US Patents: | 6 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Global Blood Theraps
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Global Blood Theraps | OXBRYTA | voxelotor | TABLET;ORAL | 213137-001 | Nov 25, 2019 | RX | Yes | Yes | 9,447,071 | Start Trial | Y | Y | Start Trial | ||
| Global Blood Theraps | OXBRYTA | voxelotor | TABLET;ORAL | 213137-001 | Nov 25, 2019 | RX | Yes | Yes | Start Trial | Start Trial | |||||
| Global Blood Theraps | OXBRYTA | voxelotor | TABLET;ORAL | 213137-001 | Nov 25, 2019 | RX | Yes | Yes | Start Trial | Start Trial | |||||
| Global Blood Theraps | OXBRYTA | voxelotor | TABLET;ORAL | 213137-001 | Nov 25, 2019 | RX | Yes | Yes | 10,017,491 | Start Trial | Y | Start Trial | |||
| Global Blood Theraps | OXBRYTA | voxelotor | TABLET;ORAL | 213137-001 | Nov 25, 2019 | RX | Yes | Yes | 9,018,210 | Start Trial | Y | Y | Start Trial | ||
| Global Blood Theraps | OXBRYTA | voxelotor | TABLET;ORAL | 213137-001 | Nov 25, 2019 | RX | Yes | Yes | 10,493,035 | Start Trial | Y | Start Trial | |||
| Global Blood Theraps | OXBRYTA | voxelotor | TABLET;ORAL | 213137-001 | Nov 25, 2019 | RX | Yes | Yes | 9,248,199 | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Global Blood Theraps Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Singapore | 11201507453V | Start Trial |
| World Intellectual Property Organization (WIPO) | 2014150289 | Start Trial |
| Peru | 20160179 | Start Trial |
| South Korea | 20160118204 | Start Trial |
| Australia | 2019275607 | Start Trial |
| Israel | 240845 | Start Trial |
| Singapore | 11201507349T | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
